(S) -JQ-35
(S) -JQ-35 (TEN-010) is a selective bromodomain and extra-terminal domain (BET) protein family inhibitor targeting BRD4, BRD3, BRD2 and BRDT. (S) -JQ-35 is orally active and can penetrate the blood-brain barrier. (S) -JQ-35 competitively binds to the bromodomain of BRD4, preventing it from binding to the Myc gene promoter, thereby inhibiting cancer cell proliferation and inducing cell apoptosis. (S) -JQ-35 can be used for targeted therapy research of malignant tumors such as NUT midline carcinoma and refractory solid tumors[1][2].
Product Specifications
CAS Number
1349719-98-7
Product Name Alternative
TEN-010
UNSPSC
12352005
Hazard Statement
H302, H315, H319
Target
Apoptosis; Epigenetic Reader Domain
Type
Reference compound
Related Pathways
Apoptosis; Epigenetics
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/JQ-35,__S_-.html
Purity
99.46
Solubility
DMSO : ≥ 85 mg/mL
Smiles
O=C(NCCCN1CCN(C)CC1)C[C@H]2C3=NN=C(C)N3C4=C(C(C)=C(C)S4)C(C5=CC=C(Cl)C=C5)=N2
Molecular Formula
C27H34ClN7OS
Molecular Weight
540.12
Precautions
H302, H315, H319
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Phase 1
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
CD34 (QBEnd/10), CF640R conjugate, 0.1mg/mL
Rhodopsin (RHO) (NM_000539) Human Over-expression Lysate
